5 completed. 4 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Xgene Pharmaceutical Group: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| XG005 for Pain Control in Subjects Undergoing Bunionectomy XG005 tablet, Placebo tablet - Acute Pain | Phase 2 / Phase 3 | Completed | Xgene Pharmaceutical Group | 450 | 2023-08-29 | 2025-11-17 |
| A Study of Topical XG004 in Participants With Osteoarthritis of the Knee XG004, Placebo - Pain | Phase 1 | Completed | Xgene Pharmaceutical Group | 32 | 2022-06-07 | 2023-05-09 |
| Phase 1 XG005-03 Topical Study XG005-03, Placebo - Pain | Phase 1 | Completed | Xgene Pharmaceutical Group | 36 | 2020-02-28 | 2021-03-25 |
| Phase 1 Pharmacokinetics, Safety, and Tolerability Study XG005, Placebos - Pain | Phase 1 | Completed | Xgene Pharmaceutical Group | 64 | 2019-07-08 | 2020-02-20 |
| Pharmacokinetics Study of XG005 Capsule XG005, Combination of Naproxen and Pregabalin, Placebos - Pain | Phase 1 | Completed | Xgene Pharmaceutical Group | 50 | 2017-10-16 | 2020-08-18 |
Pain (4) · Acute Pain (1)
Pregabalin (1)
Australia (4) · United States (1)
Feng Xu, PHD (2) · Guy Ludbrook (1)